Clinical Trial Update: Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, tolerability, PK/PD, and efficacy of repeat dosing of GSK2982772 in moderate to severe rheumatoid arthritis; completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GSK2982772 (GSK2982772)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED | Results posted: 2019-11-01